Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 23531447)

1.

Effect of intermittent dosing regimens of erlotinib on methylnitrosourea-induced mammary carcinogenesis.

Lubet RA, Szabo E, Iwata KK, Gill SC, Tucker C, Bode A, Steele VE, Juliana MM, Nicastro HL, Grubbs CJ.

Cancer Prev Res (Phila). 2013 May;6(5):448-54. doi: 10.1158/1940-6207.CAPR-12-0322. Epub 2013 Mar 26.

2.

Chemopreventive effects of the aromatase inhibitor vorozole (R 83842) in the methylnitrosourea-induced mammary cancer model.

Lubet RA, Steele VE, DeCoster R, Bowden C, You M, Juliana MM, Eto I, Kelloff GJ, Grubbs CJ.

Carcinogenesis. 1998 Aug;19(8):1345-51.

4.

Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes.

Lubet RA, Szabo E, Christov K, Bode AM, Ericson ME, Steele VE, Juliana MM, Grubbs CJ.

Mol Cancer Ther. 2008 Apr;7(4):972-9. doi: 10.1158/1535-7163.MCT-07-2141. Epub 2008 Mar 28.

5.

Influence of perinatal genistein exposure on the development of MNU-induced mammary carcinoma in female Sprague-Dawley rats.

Yang J, Nakagawa H, Tsuta K, Tsubura A.

Cancer Lett. 2000 Feb 28;149(1-2):171-9.

PMID:
10737721
6.
7.

Toxicology and carcinogenesis studies of androstenedione (CAS No. 63-05-8) in F344/N rats and B6C3F1 mice (gavage studies).

[No authors listed]

Natl Toxicol Program Tech Rep Ser. 2010 Sep;(560):1, 7-31,33-171 passim. Review.

8.

Prevention of methylnitrosourea-induced mammary cancers by 9-cis-retinoic acid and/or vitamin D3.

Cope MB, Steele VE, Eto I, Juliana MM, Hill DL, Grubbs CJ.

Oncol Rep. 2002 May-Jun;9(3):533-7.

PMID:
11956623
9.

Lapatinib, a preventive/therapeutic agent against mammary cancer, suppresses RTK-mediated signaling through multiple signaling pathways.

Li J, Cho YY, Langfald A, Carper A, Lubet RA, Grubbs CJ, Ericson ME, Bode AM.

Cancer Prev Res (Phila). 2011 Aug;4(8):1190-7. doi: 10.1158/1940-6207.CAPR-10-0330. Epub 2011 Jul 26.

10.

Efficacy of Targretin on methylnitrosourea-induced mammary cancers: prevention and therapy dose-response curves and effects on proliferation and apoptosis.

Lubet RA, Christov K, Nunez NP, Hursting SD, Steele VE, Juliana MM, Eto I, Grubbs CJ.

Carcinogenesis. 2005 Feb;26(2):441-8. Epub 2004 Dec 9.

11.

Mammary tumorigenesis in growth hormone deficient spontaneous dwarf rats; effects of hormonal treatments.

Thordarson G, Semaan S, Low C, Ochoa D, Leong H, Rajkumar L, Guzman RC, Nandi S, Talamantes F.

Breast Cancer Res Treat. 2004 Oct;87(3):277-90.

PMID:
15528971
12.

Modulation of N-methyl-N-nitrosourea induced mammary tumors in Sprague-Dawley rats by combination of lysine, proline, arginine, ascorbic acid and green tea extract.

Roomi MW, Roomi NW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M.

Breast Cancer Res. 2005;7(3):R291-5. Epub 2005 Jan 31.

13.

Effects of tamoxifen and melatonin on mammary gland cancer induced by N-methyl-N-nitrosourea and by 7,12-dimethylbenz(a)anthracene, respectively, in female Sprague-Dawley rats.

Kubatka P, Bojková B, M ciková-Kalická K, Mníchová-Chamilová M, Adámeková E, Ahlers I, Ahlersová E, Cermáková M.

Folia Biol (Praha). 2001;47(1):5-10.

PMID:
11232869
14.

Effect of reduced body weight gain on the evaluation of chemopreventive agents in the methylnitrosourea-induced mammary cancer model.

Rodríguez-Burford C, Lubet RA, Eto I, Juliana MM, Kelloff GJ, Grubbs CJ, Steele VE.

Carcinogenesis. 1999 Jan;20(1):71-6.

15.

Short-term modulation of cell proliferation and apoptosis and preventive/therapeutic efficacy of various agents in a mammary cancer model.

Christov K, Grubbs CJ, Shilkaitis A, Juliana MM, Lubet RA.

Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5488-96.

16.
17.

Prevention of N-methyl-N-nitrosourea-induced breast cancer by alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP.

Parikh RR, Gildener-Leapman N, Narendran A, Lin HY, Lemanski N, Bennett JA, Jacobson HI, Andersen TT.

Clin Cancer Res. 2005 Dec 1;11(23):8512-20.

18.

Effects of Seocalcitol (EB1089) on nitrosomethyl urea-induced rat mammary tumors.

Colston KW, Pirianov G, Bramm E, Hamberg KJ, Binderup L.

Breast Cancer Res Treat. 2003 Aug;80(3):303-11.

PMID:
14503802
19.

Efficacy of new retinoids in the prevention of mammary cancers and correlations with short-term biomarkers.

Grubbs CJ, Lubet RA, Atigadda VR, Christov K, Deshpande AM, Tirmal V, Xia G, Bland KI, Eto I, Brouillette WJ, Muccio DD.

Carcinogenesis. 2006 Jun;27(6):1232-9. Epub 2005 Dec 12.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk